ARCH Venture Management, LLC
CHICAGO, IL · CIK 1274403 · 13F filing filed 2026-08-14
Exempt reporting adviser since 2012 · limited liability company
- Private funds13 · $10.5bn gross assets
- Websitearchventure.com
- Form ADV · 2026-03-30SEC adviser record
- Kindventure
- Others nearbyChicago, IL, Mercer Island, WA
As an employer
- Offices in1 country
- Private fundsventure capital 13
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| Chicago, IL (main office)United States | |
| Mercer Island, WAUnited States | 1 |
US visa salary filings
- Filings FY20251
- Median salary offered$157,394
- Middle half$157,394 – $157,394
- Job titles1
| Job title | Filings | Median |
|---|---|---|
| PrincipalChicago, IL | 1 | $157,394 |
Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: ARCH Venture Management, LLC.
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| PARABILIS MEDICINES INC PBLS | $175.5m15.95% | New |
| BEAM THERAPEUTICS INC BEAM | $155.8m14.16% | Unchanged |
| RAPPORT THERAPEUTICS INC RAPP | $155.4m14.12% | Unchanged |
| SEAPORT THERAPEUTICS INC SPTX | $136.6m12.42% | New |
| ERASCA INC ERAS | $129.9m11.81% | Unchanged |
| VIR BIOTECHNOLOGY INC VIR | $129.4m11.76% | Reduced -222.5k |
| MAZE THERAPEUTICS INC MAZE | $123.0m11.18% | Unchanged |
| LYELL IMMUNOPHARMA INC LYEL | $45.5m4.14% | Unchanged |
| GENERATE BIOMEDICINES INC GENB | $32.8m2.98% | Unchanged |
| 10X GENOMICS INC TXG | $8.4m0.76% | Unchanged |
| BOUNDLESS BIO INC BOLD | $6.7m0.61% | New |
| GOSSAMER BIO INC GOSS | $1.3m0.12% | Unchanged |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| Q32 BIO INC QTTB | $2.1m320.5k shares |